← Scoopfeeds — Intelligent news, curated.
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6
business

Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6

Yahoo Finance · May 14, 2026, 3:39 PM · Also reported by 4 other sources

Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com UBS cuts Wix.com stock price target on margin pressure to $68 Investing.com Oppenheimer reiterates Perform rating on SAP stock after analyst day Investing.com UBS raises Cisco stock price target to $132 on AI order strength Investing.com UBS cuts Jack In The Box stock price target to $14 on weak sales

More in business

CNBC
Musk's China trip during OpenAI trial prompts apology from his lawyer for his absence
Investing.com
Earnings call transcript: ABB India Q1 2026 sees mixed results amid challenges
Investing.com
BoE’s Pill calls for ’prompt but modest’ rate hike to quell inflation pressure
CNBC
Crypto industry scores win as Clarity Act regulation bill clears Senate hurdle
Investing.com
Apple stock dips 1% on report of strained OpenAI partnership
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop